ILK and meningioma: The Cpd22-based inhibition of ILK was shown to be efficient in controlling meningioma cells through the regulation of crucial proteins and pathways linked to tumorigenesis and metastasis, establishing the therapeutic potential of targeting ILK with regard to the regulation of proliferation, angiogenesis, apoptosis, and metastasis in high-grade meningioma.